A Closer Look at Global Health Research and Development

By HEOR Staff Writer

December 29, 2023

Advancing Health Research on a Global Scale

Global Observatory on Health Research and Development (R&D) of the World Health Organisation (WHO) has just debuted its most current results. The report’s depiction of severe inequalities in the allocation of resources, money, and capacity for global health research was not unexpected. There is obviously a divide between nations with high incomes and those with low or medium incomes. The publication of this finding in the journal Health Research Policy and Systems highlights the importance of thoroughly reevaluating strategies and financial decisions for health research and development.

The Critical Need to Resolve Past Inequities

The recent COVID-19 pandemic and other outbreaks such as mpox underscore the urgent need for a fairer allocation of health research funds. Despite numerous discussions and proposals, the disparity in resource distribution between wealthy and poor nations remains largely unaddressed. This issue is critical not only for disaster preparedness but also for the global goal of improving population health equitably.

Important Results from the Worldwide Health Research and Development Project

The report highlighted four major issues. In 2020, low-income nations received just 0.2% of all grant funding, highlighting the huge disparity in this area. As a second point, the disparity in research capacity is exacerbated by the fact that high-income nations have around 56 times more health researchers per million resident than low-income countries. Third, there is a dearth of research training possibilities in low-income nations due to the low density of higher education institutions relative to the population. Finally, the suggested goals for health R&D spending as a proportion of GDP were unmet by a number of nations.

The Need to Take Action

Consistent gaps in health research capacity and financing are highlighted by the results. There has been no improvement in decades of acknowledgment. The paper recommends a systematic approach to data collection and prioritises research. It promotes frequent data exchange and advocates for global collaboration in solving these problems.

The Global Observatory on Health Research and Development remains a vital tool today. It monitors and analyses data on health research and development. It highlights both the opportunities and challenges in this crucial sector. If the international community collaborates to bridge the knowledge gap, we can improve health outcomes for all. 

Reference url

Recent Posts

Inflation Reduction Act Impact on Clinical Trial Investment Trends

By João L. Carapinha

March 26, 2026

The Inflation Reduction Act Impact is becoming evident in early data on industry-sponsored clinical trials. A recently published JME article examines how the Drug Price Negotiation Program (DPNP) introduced by the IRA may be altering investment incentives for biopharmaceutical innovation.
EU Alzheimer Approval Challenges: Anavex Withdraws Blarcamesine Application Amid Regulatory Hurdles
Anavex Life Sciences has withdrawn its marketing authorization application for blarcamesine in early Alzheimer’s disease following feedback from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP). EU Alzheimer Approval Challenges remain a significant hurdle for ...
South Africa Health Reform: Revitalizing the Crisis-Stricken Sector
South Africa health reform is urgently needed to reverse the deepening crisis in the country’s public and private health sectors. Sustained real-term declines in public per-capita spending, massive provincial debt, critical staff shortages, and uncontrolled private-sector cost escalation are coll...